SEC Form D · filed February 12, 2024
Octagon Therapeutics, Inc
Offering
$12.4M
Sold
$11.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PROVIDENCE, RI
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (6)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗